Skip to main content
letter
. 2024 Sep 4;26(3):454–457. doi: 10.5853/jos.2024.00787

Table 1.

Comparison of clinical and histological findings according to thrombus fragility

Total (n=310) Fragile thrombus (n=115) No fragile thrombus (n=195) P
Demographics and stroke risk factors
 Age (yr) 70.9±13.6 70.8±13.7 70.9±13.6 0.951
 Male sex 153 (49.4) 57 (49.6) 96 (49.2) 0.955
 Hypertension 224 (72.3) 80 (69.6) 144 (73.8) 0.416
 Diabetes 100 (32.3) 34 (29.6) 66 (33.8) 0.436
 Dyslipidemia 81 (26.1) 24 (20.9) 57 (29.2) 0.106
 Current smoking 40 (12.9) 15 (13.0) 25 (12.8) 0.955
 Coronary artery occlusive disease 46 (14.8) 14 (12.2) 32 (16.4) 0.311
 Atrial fibrillation 178 (57.4) 78 (67.8) 100 (51.3) 0.004
Clinical conditions
 Initial NIHSS score 14.0 [9.0–18.0] 15.0 [10.0–18.0] 12.0 [8.0–18.0] 0.089
 Intravenous tPA administration 114 (36.8) 47 (40.9) 67 (34.4) 0.251
 Location of occlusions <0.001
  Internal carotid artery 84 (27.1) 47 (40.9) 37 (19.0)
  M1 segment of middle cerebral artery 120 (38.7) 41 (35.7) 79 (40.5)
  M2 segment of middle cerebral artery 75 (24.2) 21 (18.3) 54 (27.7)
  Anterior cerebral artery 1 (0.3) 0 (0.0) 1 (0.5)
  Vertebrobasilar artery 26 (8.4) 4 (3.4) 22 (11.3)
  Posterior cerebral artery 4 (1.3) 2 (1.7) 2 (1.0)
 Tandem occlusion 26 (8.4) 10 (8.7) 16 (8.2) 0.880
 Onset-to-puncture time (min) 292.0 [167.0–610.0] 267.0 [138.0–571.0] 308.0 [176.0–624.0] 0.210
 Use of balloon guide catheter* 278 (89.7) 108 (99.1) 170 (99.4) 0.747
Endovascular outcomes
 Recanalization status
  Successful recanalization 287 (92.6) 104 (90.4) 183 (93.8) 0.268
  Complete recanalization 193 (62.3) 37 (32.2) 156 (80.0) <0.001
  First-pass effect 102 (32.9) 5 (4.4) 97 (49.7) <0.001
 Number of passes of stent retriever 2.3±1.4 2.8±1.3 2.0±1.4 <0.001
 Puncture-to-recanalization time (min) 31.0 [20.0–49.5] 33.5 [24.0–53.0] 29.0 [19.0–49.0] 0.128
Thrombus composition (%)
 Erythrocyte 35.6 [20.3–46.7] 40.2 [30.7–51.4] 31.0 [16.6–43.3] <0.001
 Platelet 9.7 [4.3–19.5] 8.9 [3.8–17.4] 10.9 [4.5–20.7] 0.057
 Fibrin 32.3 [21.2–47.2] 31.6 [21.0–48.1] 32.7 [21.4–45.7] 0.875
 Leukocytes 8.5 [4.2–15.7]
  Lymphocyte 0.3 [0.2–0.5] 0.3 [0.2–0.5] 0.2 [0.1–0.4] 0.135
  Neutrophil 0.6 [0.2–2.1] 0.7 [0.2–2.5] 0.6 [0.2–2.0] 0.813
  Monocyte 5.0 [2.2–11.1] 5.1 [2.3–10.7] 4.9 [2.1–11.6] 0.989
 Tissue factor 12.8 [1.5–42.7] 13.9 [1.9–45.1] 11.8 [1.1–41.0] 0.608
 Neutrophil extracellular trap 2.7 [1.1–5.1] 3.0 [1.1–6.4] 2.7 [1.1–4.6] 0.368

Values represent mean±standard deviation, number (%), or median [interquartile range].

NIHSS, National Institutes of Health Stroke Scale; tPA, tissue-type plasminogen activator.

*

The calculation of the percentages of patients using a balloon-guided catheter was limited to those with anterior circulation stroke;

Successful recanalization was defined as achieving final modified Thrombolysis In Cerebral Infarction (mTICI) 2b or 3; Complete recanalization was defined as the attainment of a final mTICI score of 3.